Fixed-dose sumatriptan/naproxen sodium compared with each monotherapy utilizing the novel composite endpoint of sustained pain-free/no adverse events

Therapeutic Advances in Neurological Disorders

Volumn 2, Issue 3, 2009, Pages 135-141

  Landy, Stephen ^a   White, Jonathan ^b   Lener, Shelly E ^b   Mcdonald, Susan A ^b  

^a Wesley Headache Clinic   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Efficacy; Headache; Migraine; Safety; Sumatriptan naproxen sodium; Sustained pain free; Tolerability

Indexed keywords

NAPROXEN; NAPROXEN PLUS SUMATRIPTAN; SUMATRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MONOTHERAPY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

EID: 77953393583     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285609102769     Document Type: Article

References (20)

1. Brandes, J.L., Kudrow, D., Cady, R., Tiseo, P.J., Sun, W. and Sikes, C.R. (2005) Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing. Cephalalgia 25: 735-742.
2. Brandes, J.L., Kudrow, D., Stark, S.R., O'Carroll, C.P., Adelman, J.U., O'Donnell, F.J. et al. (2007) Sumatriptan-naproxen for acute treatment of migraine. JAMA 297: 1443-1454.
3. Cady, R.K., Sheftell, F., Lipton, R.B., O'Quinn, S., Jones, M., Diamond, M.L. et al. (2000) Effects of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials. Clin Ther 22: 1035-1048.
4. Carpay, J., Schoenen, J., Ahmad, F., Kinrade, F. and Boswell, D. (2004) Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. Clin Ther 26: 214-223.
5. Dodick, D.W., Sandrini, G. and Williams, P. (2007) Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS Drugs 21: 73-82.
6. Ferrari, M.D., Roon, K.I., Lipton, R.B. and Goadsby, P.J. (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358: 1668-1675.
7. Goadsby, P.J., Zanchin, G., Geraud, G., de Klippel, N., Diaz-Insa, S., Gobel, H. et al. (2008) Early vs non-early intervention in acute migraine - ‘Act when Mild (AwM).’ A double-blind, placebo-controlled trial of almotriptan. Cephalalgia 28: 383-391.
8. Headache Classification Committee of the International Headache Society (1988) Classification of headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl. 7): 1-96.
9. Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. 2nd edn. Cephalalgia (Suppl. 1): 9-160.
10. Lanteri-Minet, M. (2005) What do patients want from their acute migraine therapy? Eur Neurol 53(Suppl. 1): 3-9.
11. Lipton, R.B., Hamelsky, S.W. and Dayno, J.M. (2002) What do patients with migraine want from acute migraine treatment? Headache 42(Suppl. 1): 3-9.
12. Mathew, N.T., Finlayson, G., Smith, T.R., Cady, R.K., Adelman, J. and Mao, L. (2007) Early intervention with almotriptan: results of the AEGIS trial (Axert Early Migraine Intervention Study). Headache 47: 189-198.
13. Mathew, N.T., Kailasam, J. and Meadors, L. (2004) Early treatment of migraine with rizatriptan: a placebo-controlled study. Headache 44: 669-673.
14. Loder, E., Freitag, F.G., Adelman, J., Pearlmand, S. and Abu-Shakra, S. (2005) Zolmitriptan study 014 group. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo-controlled trial. Curr Med Res Opin 21: 381-389.
15. Pascual, J., Mateos, V., Roig, C., Sanchez-Del-Rio, M. and Jiminez, D. (2007) Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache 47: 1152-1168.
16. Silberstein, S.D. (1995) Migraine symptoms: results of a survey of self-reported migraineurs. Headache 35: 387-396.
17. Silberstein, S.D., Mannix, L.K., Goldstein, J., Couch, J.R., Byrd, S.C., Ames, M.H. et al. (2008) Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. Neurology 71: 114-121.
18. Scholpp, J., Schellenberg, R., Moeckesch, B. and Banik, N. (2004) Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia 24: 925-933.
19. Williams, P. and Reeder, C.E. (2003) Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine. Clin Ther 25: 2903-2919.
20. Williams, P. and Reeder, C.E. (2004) A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy / tolerability endpoint. J Manag Care Pharm 10: 259-265.